Denali Therapeutics (DNLI) EPS (Basic) (2017 - 2026)
Denali Therapeutics (DNLI) posted quarterly EPS (Basic) of -$0.69 for Q1 2026, up 12.89% year-over-year from -$0.61 in Q1 2025, and up 9.19% quarter-over-quarter from -$0.76 in Q4 2025.
Denali Therapeutics (DNLI) EPS (Basic) (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has reported EPS (Basic) for 10 consecutive years, with -$0.69 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 12.89% year-over-year to -$0.69; the TTM figure through Mar 2026 stood at -$3.01 (down 10.89% YoY), while the FY2025 annual figure was -$2.97, down 15.49% from the prior year.
- EPS (Basic) rose to -$0.69 in Q1 2026 per DNLI's latest filing, from -$0.76 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.34 in Q2 2023 and bottomed at -$1.0 in Q2 2025.
- Historically, EPS (Basic) has averaged -$0.61 across 5 years, with a median of -$0.72 in 2023.
- Annual changes were most pronounced in 2023 — EPS (Basic) surged 379.96% — and 2024, when it slumped 145.1%.
- Denali Therapeutics' EPS (Basic) stood at -$0.79 in 2022, then slipped by 10.64% to -$0.87 in 2023, then rose by 17.81% to -$0.71 in 2024, then retreated by 6.49% to -$0.76 in 2025, then advanced by 9.19% to -$0.69 in 2026.
- Business Quant data shows DNLI's EPS (Basic) at -$0.69 in Q1 2026, -$0.76 in Q4 2025, and -$0.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn | -0.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.70 |
| Mar 31, 2026 | -0.69 |
| Dec 31, 2025 | -0.76 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -0.79 |
| Dec 31, 2024 | -0.71 |
| Sep 30, 2024 | -0.65 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -0.87 |
| Sep 30, 2023 | -0.72 |
| Jun 30, 2023 | 1.34 |
| Mar 31, 2023 | -0.83 |
| Dec 31, 2022 | -0.79 |
| Sep 30, 2022 | -0.84 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | -0.62 |
| Sep 30, 2021 | -0.69 |